Cancer BiologyCell Death and DiseasePeer-reviewed
CDK4/6 Inhibition Uncovers Subtype-Specific Vulnerabilities and Immune-Related Responses in Esophageal Squamous Cell Carcinoma.
Fabiana Moresi, Diego Japón-Ruiz, Matteo Serra…·Xavier Bisteau
This study evaluates palbociclib as a first-line therapy in eSCC, identifying response subtypes and showing immune activation through replication stress and DNA damage.
2 citations